1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025
Read More Disease What Is The Difference Between Laryngeal Cancer And Pharyngitis? What Is The Way To Confirm The Diagnosis Of Laryngeal Cancer? Apr 15, 2025